NeuPath Health Inc. NPTH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 64.38M | 64.68M | 62.47M | 60.07M | 56.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.38M | 64.68M | 62.47M | 60.07M | 56.91M |
| Cost of Revenue | 52.34M | 52.44M | 50.58M | 48.51M | 46.05M |
| Gross Profit | 12.04M | 12.24M | 11.89M | 11.57M | 10.87M |
| SG&A Expenses | 8.69M | 8.85M | 8.79M | 8.25M | 7.78M |
| Depreciation & Amortization | 1.63M | 1.62M | 1.64M | 1.66M | 1.67M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.65M | 62.90M | 61.01M | 58.41M | 55.50M |
| Operating Income | 1.73M | 1.77M | 1.46M | 1.66M | 1.41M |
| Income Before Tax | 674.20K | 442.50K | -33.90K | 135.00K | -81.90K |
| Income Tax Expenses | -506.00K | 226.70K | 254.50K | 312.50K | 264.20K |
| Earnings from Continuing Operations | 1.18 | 0.22 | -0.29 | -0.18 | -0.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -206.10K | -205.40K | -217.20K | -209.80K | -224.20K |
| Net Income | 973.90K | 10.20K | -505.80K | -387.40K | -570.30K |
| EBIT | 1.73M | 1.77M | 1.46M | 1.66M | 1.41M |
| EBITDA | 3.13M | 3.17M | 2.88M | 3.08M | 2.85M |
| EPS Basic | 0.02 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| EPS Diluted | 0.02 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 225.28M | 225.52M | 225.45M | 225.64M | 225.58M |
| Average Diluted Shares Outstanding | 234.03M | 231.91M | 229.80M | 229.99M | 228.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |